Tata India Pharma & Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹8689 Cr | ₹1208 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 05 Jun 2004 | 28 Dec 2015 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | Nifty Pharma TRI |
| Turn Over | 21% | 26.49% |
| Expense Ratio | 1.81 | 2.14 |
| Manager | Sailesh Raj Bhan | Meeta Shetty |
| ISIN Code | INF204K01968 | INF277K016A9 |
| Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Month | -3.66% | -3.04% |
| 6 Month | 7.39% | 9.88% |
| 1 Year | 21.43% | 27.65% |
| 3 Year | 19.27% | 20.65% |
| 5 Year | 25.83% | 25.56% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 14.69% | 19.99% |
| 3 Year | 27.2% | 29.34% |
| 5 Year | 22.9% | 23.84% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Year | 17.79% | 6.67% |
| 3 Year | 20.87% | 17.46% |
| 5 Year | 20.18% | 14.22% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Standard Deviation | 14.36% | 14.23% |
| Sharp | 0.78% | 0.74% |
| Beta | 0.87% | 0.9% |
| Alpha | 1.67% | 2.85% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Name | Sailesh Raj Bhan | Meeta Shetty |
| Total AUM | ₹96086 Cr | ₹17847 Cr |
| Fund Manage | 5 | 5 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 4.4 | 5.39 |
| Large Cap | 45.96 | 40.33 |
| Mid Cap | 27.12 | 30.82 |
| Small Cap | 22.52 | 23.46 |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 4.4 | 5.39 |
| Pharmaceuticals & Biotechnology | 75.86 | 76.28 |
| Healthcare Services | 17.38 | 14.31 |
| Retailing | 2.36 | 0.66 |
| Fertilizers & Agrochemicals | - | 0.83 |
| Chemicals & Petrochemicals | - | 0.39 |
| Insurance | - | 2.14 |
Top Comparisons
Nippon India Innovation Fund - Regular (G)
3Y Returns0%
Quant ESG Equity Fund Regular - Growth
3Y Returns17.06%
ICICI Prudential Multi-Asset Fund - Growth
3Y Returns17.89%
Motilal Oswal Multi Asset Fund - Regular Plan - Growth Option
3Y Returns4.23%
Bandhan ELSS Tax saver Fund - Regular Plan - Growth
3Y Returns12.59%
Motilal Oswal ELSS Tax Saver Fund (MOFLTE) - Regular Plan - Growth Option
3Y Returns21.58%
SBI Banking & Financial Services Fund - Regular Plan - Growth
3Y Returns14.26%
Mirae Asset Banking and Financial Services Fund Regular Growth
3Y Returns11.58%